TrialEndocrine journal2024

Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4).

Akira Shimatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.